BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36234741)

  • 1. Hybrids of 1,4-Quinone with Quinoline Derivatives: Synthesis, Biological Activity, and Molecular Docking with DT-Diaphorase (NQO1).
    Kadela-Tomanek M; Jastrzębska M; Chrobak E; Bębenek E; Latocha M
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
    Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
    Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
    Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
    Winski SL; Swann E; Hargreaves RH; Dehn DL; Butler J; Moody CJ; Ross D
    Biochem Pharmacol; 2001 Jun; 61(12):1509-16. PubMed ID: 11377380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkynyloxy derivatives of 5,8-quinolinedione: Synthesis, in vitro cytotoxicity studies and computational molecular modeling with NAD(P)H:Quinone oxidoreductase 1.
    Kadela-Tomanek M; Jastrzębska M; Pawełczak B; Bębenek E; Chrobak E; Latocha M; Książek M; Kusz J; Boryczka S
    Eur J Med Chem; 2017 Jan; 126():969-982. PubMed ID: 28006669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and spectral characterisation of 2-amino-2H-[1,2,3]triazolo[4,5-g]quinoline-4,9-dione polymorphs. Cytotoxic activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Jastrzębska M; Chrobak E; Bębenek E; Latocha M; Kusz J; Boryczka S
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Apr; 230():118038. PubMed ID: 31945713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of quinolinedione-linked sulfonylpiperazine derivatives as NQO1-directed antitumor agents.
    Guo K; Li J; Jia Y; Yang X; Yan X; Wu L
    Bioorg Chem; 2023 Mar; 132():106385. PubMed ID: 36696730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
    Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
    Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
    Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
    Gasdaska PY; Fisher H; Powis G
    Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis.
    Chaaban I; Hafez H; AlZaim I; Tannous C; Ragab H; Hazzaa A; Ketat S; Ghoneim A; Katary M; Abd-Alhaseeb MM; Zouein FA; Albohy A; Amer AN; El-Yazbi AF; Belal ASF
    Bioorg Chem; 2021 Aug; 113():105035. PubMed ID: 34091287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies.
    Hassani M; Cai W; Koelsch KH; Holley DC; Rose AS; Olang F; Lineswala JP; Holloway WG; Gerdes JM; Behforouz M; Beall HD
    J Med Chem; 2008 Jun; 51(11):3104-15. PubMed ID: 18457384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
    Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
    Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diosgenin-1,4-quinone hybrids: Synthesis, antitumor evaluation, and mechanism studies.
    Li G; Li Q; Sun H; Li W
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105993. PubMed ID: 34478831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinone-induced apoptosis in human colon adenocarcinoma cells via DT-diaphorase mediated bioactivation.
    Sun X; Ross D
    Chem Biol Interact; 1996 May; 100(3):267-76. PubMed ID: 8653808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.